Tests:CA 19-9: Difference between revisions
Tests:CA 19-9
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Overview == | ||
|- | |- | ||
|Department | |Department | ||
| Line 19: | Line 19: | ||
19-9 | 19-9 | ||
|- | |||
|Test Availability | |||
|Tuesdays and Fridays | |||
Contact the laboratory if testing required urgently. | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
| Line 27: | Line 31: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Specimen Requirements == | ||
|- | |- | ||
|Specimen Type | |Specimen Type | ||
|Serum | |Serum | ||
Plasma | Plasma | ||
|- | |||
|Specimen Transportation | |||
| | |||
|- | |- | ||
|Preferred | |Preferred | ||
| Line 39: | Line 46: | ||
|SST <span style="background: #fbec5d"> Yellow-Top</span> | |SST <span style="background: #fbec5d"> Yellow-Top</span> | ||
|- | |- | ||
| | |Unacceptable | ||
| | | | ||
|- | |- | ||
| Line 46: | Line 53: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Aliquot Requirements == | ||
|- | |- | ||
|Sample Type | |Sample Type | ||
|>500 uL | |Serum | ||
|- | |||
|Preferred Volume | |||
|>500 uL | |||
|- | |- | ||
|Minimum Volume | |Minimum Volume | ||
|200 uL | |200 uL | ||
|- | |- | ||
|Aliquot Transportation | |Aliquot Transportation | ||
| Line 58: | Line 68: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Clinical Information == | ||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 75: | Line 85: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Comments == | ||
|- | |- | ||
| colspan="2" | | | colspan="2" |Used for monitoring gastrointestinal malignancies | ||
Used for monitoring gastrointestinal malignancies | |||
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | ||
|} | |} | ||